Relay Therapeutics Inc
RLAY
$18.74-3.35%
End of day · as of Oct 6, 2026, 11:30 PM ET
Mkt cap
$3.39B
EV/Sales
215.4
P/E ratio
N/A
FY2025 Revenue
$15.36M
EPS (TTM)
$-1.56
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1800.58%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported RLAY revenue for 2025-12-31 was $15.4M. Net income was -$276.5M. Revenue was up 53.4% from 2024-12-31 to 2025-12-31. RLAY currently screens at market cap $3.39B.
Use this RLAY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RLAY income, balance, and cash tables.
Relay Therapeutics Inc (RLAY) is a biotechnology company in the Healthcare sector.
Latest cached Relay Therapeutics Inc (RLAY) revenue for Dec 31, 2025 was $15.4M. Net income was -$276.5M. Statements: https://lician.com/financials/rlay
Relay Therapeutics Inc (RLAY) market capitalization is $3.39B on the latest cached snapshot.
Relay Therapeutics Inc (RLAY) cached previous close $19.39; day range $18.17 – $19.50; volume 3,865,208. Session quote: https://lician.com/quote/rlay
Relay Therapeutics Inc (RLAY) latest cached earnings event is "RLAY earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings